SCHEMBL5244604

SCHEMBL5244604

Cn1nccc1-c1cc(NC(=O)Nc2ccccc2F)ccc1OCCC1CCCCN1

nearest known ligand 0.72

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 20/20 0.72
HTR2C P28335 19/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5244501 0.92 HTR2A (0.72) HTR2AHTR2C
SCHEMBL5243920 0.91 HTR2A (0.72) HTR2AHTR2C
SCHEMBL5243068 0.91 HTR2A (0.72) HTR2AHTR2C
SCHEMBL5244080 0.91 HTR2A (0.69) HTR2AHTR2C
SCHEMBL1165907 0.90 HTR2A (0.70) HTR2AHTR2C
SCHEMBL5243677 0.90 HTR2A (0.73) HTR2AHTR2C
SCHEMBL5246213 0.89 HTR2A (0.71) HTR2AHTR2C
SCHEMBL5242523 0.88 HTR2A (0.69) HTR2AHTR2C
SCHEMBL3948531 0.87 HTR2A (0.55) HTR2AHTR2C
SCHEMBL1165617 0.87 HTR2A (0.71) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833799-A2 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT-2a SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2007-09-19 EP claimed
WO-2006055734-A2 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2006-05-26 WO claimed
EP-1833799-A2 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT-2a SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2007-09-19 EP disclosed
WO-2006055734-A2 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2006-05-26 WO disclosed